We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

KKR Injects $60M In Slayback Pharma

Law360, New York (January 6, 2017, 1:03 PM EST) -- Pharmaceutical research and development company Slayback Pharma LLC said Thursday that it has received a $60 million investment from private equity giant KKR & Co. to help accelerate the development of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.